These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 25060380)

  • 21. Should ranolazine be used for all patients with ischemic heart disease or only for symptomatic patients with stable angina or for those with refractory angina pectoris? A critical appraisal.
    Thadani U
    Expert Opin Pharmacother; 2012 Dec; 13(17):2555-63. PubMed ID: 23121448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ranolazine and late cardiac sodium current--a therapeutic target for angina, arrhythmia and more?
    Makielski JC; Valdivia CR
    Br J Pharmacol; 2006 May; 148(1):4-6. PubMed ID: 16520741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ranolazine: clinical applications and therapeutic basis.
    Hawwa N; Menon V
    Am J Cardiovasc Drugs; 2013 Feb; 13(1):5-16. PubMed ID: 23335347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The patient with chronic ischemic heart disease. Role of ranolazine in the management of stable angina.
    Di Monaco A; Sestito A
    Eur Rev Med Pharmacol Sci; 2012 Nov; 16(12):1611-36. PubMed ID: 23161033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does ranolazine have a place in the treatment of acute coronary syndromes?
    Newby LK; Peterson ED
    JAMA; 2007 Apr; 297(16):1823-5. PubMed ID: 17456825
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical experience with ranolazine in a veteran population with chronic stable angina.
    Reeder DN; Gillette MA; Franck AJ; Frohnapple DJ
    Ann Pharmacother; 2012 Jan; 46(1):42-50. PubMed ID: 22215689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ranolazine: a novel agent that improves dysfunctional sodium channels.
    Pham DQ; Mehta M
    Int J Clin Pract; 2007 May; 61(5):864-72. PubMed ID: 17493093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FDA okays new drug for tough-to-treat chest pain.
    Harv Heart Lett; 2006 Apr; 16(8):7. PubMed ID: 19685562
    [No Abstract]   [Full Text] [Related]  

  • 29. Impact of ranolazine on clinical outcomes and healthcare resource utilization in patients with refractory angina pectoris.
    Ling H; Packard KA; Burns TL; Hilleman DE
    Am J Cardiovasc Drugs; 2013 Dec; 13(6):407-12. PubMed ID: 23873327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Relative improvement of the quality of life (interview by Philip Gräzel)].
    Bauersachs J
    MMW Fortschr Med; 2012 Oct; 154(18):81. PubMed ID: 23156883
    [No Abstract]   [Full Text] [Related]  

  • 31. Novel drugs for treating angina.
    Jones DA; Timmis A; Wragg A
    BMJ; 2013 Sep; 347():f4726. PubMed ID: 24018101
    [No Abstract]   [Full Text] [Related]  

  • 32. Chronic angina and the treatment with ranolazine: facts and recommendations.
    Milne HC; Vallerand AH
    Prog Cardiovasc Nurs; 2009 Sep; 24(3):90-5. PubMed ID: 19737166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucose-Lowering Medications and Angina Burden in Patients with Stable Coronary Disease: results from the Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina (TERISA) Trial.
    Arnold SV; McGuire DK; Spertus JA; Tang F; Yue P; Inzucchi SE; Belardinelli L; Chaitman BR; Kosiborod M
    Am Heart J; 2015 Oct; 170(4):753-759.e2. PubMed ID: 26386799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Chronic ischemic heart diseases. Effectively alleviating ischemia symptoms].
    MMW Fortschr Med; 2012 Oct; 154(18):80-1. PubMed ID: 23156882
    [No Abstract]   [Full Text] [Related]  

  • 35. Ranolazine: an antianginal drug with antiarrhythmic properties.
    Tamargo J; Caballero R; Delpón E
    Expert Rev Cardiovasc Ther; 2011 Jul; 9(7):815-27. PubMed ID: 21809962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ranolazine for chronic stable angina.
    Nash DT; Nash SD
    Lancet; 2008 Oct; 372(9646):1335-41. PubMed ID: 18929905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of ranolazine on exercise tolerance and angina frequency in patients with severe chronic angina receiving maximally-tolerated background therapy: analysis from the Combination Assessment of Ranolazine In Stable Angina (CARISA) randomized trial.
    Sendón JL; Lee S; Cheng ML; Ben-Yehuda O;
    Eur J Prev Cardiol; 2012 Oct; 19(5):952-9. PubMed ID: 22689417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacologic management of chronic stable angina.
    Dixit D; Kimborowicz K
    JAAPA; 2015 Jun; 28(6):. PubMed ID: 25989429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biomarker bonanza?
    Califf RM; Shah SH; Newby LK
    J Am Coll Cardiol; 2010 Mar; 55(12):1197-1199. PubMed ID: 20298925
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hypertrophic cardiomyopathy with restrictive pathophysiology: is there a role for cardiopulmonary exercise testing?].
    Correale M; Passero T; Totaro A; Di Biase M
    G Ital Cardiol (Rome); 2012 Dec; 13(12):861; author's reply p.861. PubMed ID: 23196690
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.